PI Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
PIIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
PI Industries' board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025, with Price Waterhouse issuing an unmodified (clean) opinion. A final dividend of Rs. 10 per share (1000% on face value of Re. 1) was recommended, taking total FY25 dividend to Rs. 16 per share (including Rs. 6 interim already paid). The 78th AGM is scheduled for August 14, 2025, with record date August 7, 2025. Key leadership changes include re-appointment of Vice Chairperson & MD Mayank Singhal for 5 years and Joint MD Rajnish Sarna for 3 years, alongside new independent and non-executive director appointments. Makarand M. Joshi & Co. was appointed as Secretarial Auditor for 5 years (FY26–FY30), and K.G. Goyal & Co. re-appointed as Cost Auditor for FY26. One key audit matter was flagged around valuation of the company's investment in wholly owned subsidiary PI Health Sciences (equity Rs. 533 crore + OCDs Rs. 658 crore), but no impairment was deemed necessary.
A clean audit opinion and a robust total dividend of Rs. 16/share (yielding a healthy payout) are positive for shareholders. Continuity of the senior leadership team signals stability. Investors will need to wait for the actual financial figures in the detailed results to assess revenue and profit growth.